Nanostructured lipid systems as a strategy to improve the in Vitro cytotoxicity of ruthenium(II) compounds

Molecules

Volumn 19, Issue 5, 2014, Pages 5999-6008

  De Freitas, Eduardo Sinesio ^a   Da Silva, Patricia Bento ^a   Chorilli, Marlus ^a   Batista, Alzir Azevedo ^b   De Oliveira Lopes, Érica ^a   Da Silva, Monize Martins ^b   Leite, Clarice Queico Fujimura ^a   Pavan, Fernando Rogério ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Nanostructured lipid systems; Ruthenium complexes; Tuberculosis

Indexed keywords

LIPID; NANOMATERIAL; RUTHENIUM;

CHEMISTRY; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

HUMANS; LIPIDS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NANOSTRUCTURES; RUTHENIUM; TUBERCULOSIS;

EID: 84901458830     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19055999     Document Type: Article

References (23)

1. Anil, K.; Arnould, L.; Lounis, N.; Guillemont, J.; Andries, K. The challenge of new drug discovery for tuberculosis. Nature 2011, 469, 483-490.
2. World Health Organization (WHO). Basic facts on tuberculosis (TB) in the WHO European Region, 2012. Available online: http://www.euro.who.int/en/health- Topics/communicablediseases/tuberculosis/data-And-statistics (accessed on 5 January 2014).
3. Guido, R.; Andricopulo, A.; Oliva, G. Drug design, biotechnology and medicinal chemistry: Applications in infectious diseases. Adv. Stud. 2010, 24, 70.
4. Rosalba, L.D.; Meckesl, M.; Fernandez, S.S.; Salinas, G.M.; Vilarreal, J.V.; Torres, J.; Herrera, J.L.; Arellanes, A.J. Antimycobacterial neolignans isolated from Aristolochia taliscana. Mem. Inst. Oswaldo-Cruz. 2010, 105, 45-51.
5. Pereira, G.A.; Massabni, A.C.; Castellano, E.E.; Costa, L.C.S.; Leite, C.Q.F.; Pavan, F.R.; Cuin, A. A broad study of two new promising antimycobacterial drugs: Ag(I) and Au(I) complexes with 2-(2-Thienyl) benzothiazole. Polyhedron 2012, 38, 291-296.
6. 2O. J. Mol. Struct. 2013, 1036, 180-187.
7. Pavan, F.R.; Poelhsith, G.V.; da Cunha, L.V.P.; Barbosa, M.I.F.; Leite, S.R.A.; Batista, A.A.; Cho, S.H.; Franzblau, S.G.; de Camargo, M.S.; Resende, F.A.; et al. In vitro and in vivo activities of ruthenium(II) phosphine/diimine/picolinate complexes (SCAR) against Mycobacterium tuberculosis. PLoS One 2013, 8, 1-10.
8. Pavan, F.R.; Poelhsitz, G.V.; Barbosa, M.I.F.; Leite, S.R.A.; Batista, C.; Ellena, J.; Sato, L.S; Franzblau, S.G.; Moreno, V.; Gambino, D.; et al. Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis. Eur. J. Med. Chem. 2011, 46, 5099-5107.
9. Pavan, F.R.; Poelhsitz, G.V.; Nascimento, F.B.; Leite, S.R.A.; Batista, A.A.; Deflon, V.M.; Sato, D.N.; Franzblau, S.G.; Leite, C.Q.F. Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents. Eur. J. Med. Chem. 2010, 45, 598-601.
10. Formariz, T.P.; Urban, M.T.C.; Silva Junior, A.A.; Gremião, M.P.D.; Oliveira, A.G. Microemulsion and liquid cristals as drug delivery systems Rev. Bras. Cienc. Farm. 2005, 41, 301-313.
11. Bonifacio, B.V.; Silva, P.B.; Ramos, M.A.R.; Negri, K.M.S.; Bauab, T.M.; Chorilli, M. Nanotechnology-based drug delivery systems and herbal medicines: A review. Int. J. Nanomed. 2014, 9, 1-15.
12. Sintov, A.C.; Shapiro, L. New microemulsions vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J. Controlled Release 2004, 95, 173-183.
13. Vandamme, T.F. Microemulsions as ocular drug delivery systems: Recent developments and future challenges. Prog. Retin. Eye Res. 2002, 21, 15-34.
14. Cunha Junior, A.; Fialho, S.L.; Carneiro, L.B.; Oréfice, F. Microemulsions as drug delivery systems for topical ocular administration. Arq. Bras. Oftal. 2003, 63, 285-391.
15. Lachman, L.; Liberman, H.; Kanig, L.J. Teoria e Prática na Indústria Farmacêutica, 3rd ed.; Lea & Febiger: Philadelphia, PA, USA, 2001; p. 1143.
16. Orthaber, D.; Glatter, O. Synthetic phospholipid analogs: A structural investigation with scattering methods. Chem. Phys. Lipids 2000, 107, 179-189.
17. Orme, I. Search for new drugs for treatment of tuberculosis. Antimicrob. Agents Chemother. 2001, 45, 1943-1946.
18. Metha, S.K.; Kaur, G.; Verma, A. Fabrication of plant protein microspheres for encapsulation, stabilization and in vitro release of multiple anti-Tuberculosis drugs. Colloids Surf. A: Physicochem. Eng. Asp. 2011, 275, 219-230.
19. Formariz, T.P.; Chiavacci, L.A.; Sarmento, V.H.V.; Franzini, C.M.; Silva-, A.A., Jr.; Scarpa, M.V.; Santilli, C.V.; Egito, E.S.T.; Oliveira, A.G. Structural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and their relationship with doxorubicin release. Colloids Surf. B 2008, 63, 287-295.
20. Formariz, T.P.; Chiavacci, L.A.; Scarpa, M.V.; Silva-Júnior, A.A.; Egito, E.S.T.; Terrugi, C.H.B.; Franzini, C.M.; Sarmento, V.H.V.; Oliveira, A.G. Structure and viscoelastic behavior of pharmaceutical biocompatible anionic microemulsions containing the antitumoral drug compound doxorubicin. Colloids Surf. B 2010, 77, 47-53.
21. Palomino, J.-C.; Martin, A.; Camacho, M.; Guerra, H.; Swings, J.; Portaels, F. Resazurin microtiter assay plate: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2002, 46, 2720-2722.
22. Pavan, F.R.; Maia, P.I.; Leite, S.R.A.; Deflon, V.M.; Batista, A.A.; Sato, D.N.; Franzblau, S.G.; Leite, C.Q.F. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: Anti-Mycobacterium tuberculosis activity and cytotoxicity. Eur. J. Med. Chem. 2010, 45, 1898-1905.
23. Valdivieso-Garcia, A.; Clarke, R.C.; Rahn, K.; Durette, A.; MacLeod, D.L.; Gyles, C.L. Neutral red assay for measurement of quantitative vero cell cytotoxicity. Appl. Environ. Microbiol. 1993, 59, 1981-1983.